2022
DOI: 10.1016/j.tranon.2022.101494
|View full text |Cite
|
Sign up to set email alerts
|

Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 25 publications
(32 reference statements)
0
5
0
Order By: Relevance
“…This study aims to contribute to the ongoing advancements in DL-based diagnostics, in which molecular research on diseases and the performance of artificial intelligence-driven technologies has provided a strong impact 28 30 . The new 2021 WHO classification highlights the importance of IDH mutation and 1p/19q codeletion in the diagnosis of adult-type diffuse gliomas, which prompted us to focus on these two genetic abnormalities 3 5 .…”
Section: Discussionmentioning
confidence: 99%
“…This study aims to contribute to the ongoing advancements in DL-based diagnostics, in which molecular research on diseases and the performance of artificial intelligence-driven technologies has provided a strong impact 28 30 . The new 2021 WHO classification highlights the importance of IDH mutation and 1p/19q codeletion in the diagnosis of adult-type diffuse gliomas, which prompted us to focus on these two genetic abnormalities 3 5 .…”
Section: Discussionmentioning
confidence: 99%
“… Understand the idea of goodness-of-fit statistics. Pulmonology Tomita et al, 2022 [ 21 ] Describe the indications for using neural networks. Describe the high-level mechanism of Convolutional Neural Networks in solving classification tasks Describe the implications of neural networks in predicting mutation/tumor types.…”
Section: Methodsmentioning
confidence: 99%
“…Machine learning models have shown high performance in predicting site of origin from cancers of unknown primary, 92 or virtual prediction of cellular protein expression, 93,94 and molecular aberrations from hematoxylin and eosin glass slides alone. [95][96][97][98][99][100][101][102][103] With appropriate training data, multi-omics information can provide quantitative data for machine learning models to predict patient outcomes (e.g., survival, response to treatment). [104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119] These systems have potential to change how pathology is practiced; however, machine learning models are not replacement for human expertise.…”
Section: Machine Learning In Pathologymentioning
confidence: 99%
“…Machine learning can aid in the precision medicine era encouraging discovery of novel biomarkers and targets by identifying patterns and associations between different multimodal data (e.g., histopathology, genomic, proteomic, clinical data). Machine learning models have shown high performance in predicting site of origin from cancers of unknown primary, 92 or virtual prediction of cellular protein expression, 93,94 and molecular aberrations from hematoxylin and eosin glass slides alone 95–103 . With appropriate training data, multi‐omics information can provide quantitative data for machine learning models to predict patient outcomes (e.g., survival, response to treatment) 104–119 .…”
Section: Image Analysis and Machine Learning In Pathologymentioning
confidence: 99%